Updated:
Silverback Therapeutics
Silverback Therapeutics, a Seattle-based company founded in 2016, focuses on developing systemically delivered therapies that modulate disease pathways.
Overview
Silverback Therapeutics, a Seattle-based company founded in 2016, focuses on developing systemically delivered therapies that modulate disease pathways. The company has secured $220 million in total funding.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Additional offices
Zurich, Switzerland · Boston, MA, United States · Seattle, WA, United States · New Canaan, CT, United States
Sector focus
Frequently asked questions
Has Silverback Therapeutics made any known investments?
No public records of specific investments or portfolio companies have been identified. The firm's investment activity remains private, possibly due to its structure as an unregistered vehicle that does not require public disclosures.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: